Launches Indigo ® System Lightning™ 12 in U.S. Appoints Corey L. Teigen, M.D., as Chief Scientific Officer and James F. Benenati, M.D., FSIR, as Chief Medical ...

Lightning Flash™ is the most advanced mechanical thrombectomy system on the market to address venous and pulmonary thrombus Next generation technology combines superior catheter design with the latest ...

Data presented for the first time this week at Vascular Interventional Advances (VIVA) 2024 Conference Findings reinforce the clinical, health economic and cost benefits of computer assisted vacuum ...

NEW YORK - Penumbra, Inc. (NYSE:PEN), a $9.87 billion medical technology company with strong financial health and ~13% revenue growth over the last twelve months, announced Monday that its computer ...

Physicians in Europe now have access to Penumbra’s most advanced mechanical thrombectomy technology available, which has had a significant impact on patients in the U.S. Designed for single session ...

Latest computer assisted vacuum thrombectomy (CAVT) technologies combine superior catheter design with the latest dual clot detection computer algorithms designed to restore blood flow quickly ...

Penumbra, Inc. PEN recently received FDA clearance for the RED 62 Reperfusion Catheter. Following this regulatory go-ahead, the company has also initiated commercial availability of the catheter ...

The medical device specialist completed enrollment for a clinical trial of its latest thrombectomy product. This addresses a significant medical challenge at a time when the U.S. population is aging.

In a report released yesterday, Ryan Zimmerman from BTIG maintained a Buy rating on Penumbra (PEN – Research Report), with a price target of $264.00. Ryan Zimmerman has given his Buy rating due to a ...